about
Ticlopidine in its prodrug form is a selective inhibitor of human NTPDase1Big opportunities for small molecules in immuno-oncology.Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity.Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
@en
8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
@nl
type
label
8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
@en
8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
@nl
prefLabel
8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
@en
8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
@nl
P2093
P2860
P356
P1476
8-BuS-ATP derivatives as specific NTPDase1 inhibitors
@en
P2093
Beat Künzli
Bilha Fischer
Christine Cadot
Donald Poirier
Eric Rousseau
Irina Gillerman
Jean-Philippe Brosseau
Joanna Lecka
Mabrouka Salem
Mercedes N Munkonda
P2860
P304
P356
10.1111/BPH.12135
P407
P577
2013-05-01T00:00:00Z